What is the Drug of Choice for Kleine-Levin Syndrome and Current Pharmacological Approaches?
•
4 min read
Affecting approximately 1 to 5 people per million, Kleine-Levin Syndrome (KLS) is a rare and disabling neurological disorder. The recurrent episodes of excessive sleepiness, cognitive impairment, and behavioral changes make treatment challenging, with no single definitive answer to the question, 'What is the drug of choice for Kleine-Levin syndrome?'.
